4.7 Article

PCSK9 pathway-noncoding RNAs crosstalk: Emerging opportunities for novel therapeutic approaches in inflammatory atherosclerosis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

Neutrophil to lymphocyte ratio is not related to carotid atherosclerosis progression and cardiovascular events in the primary prevention of cardiovascular disease: Results from the IMPROVE study

Massimo R. Mannarino et al.

Summary: Inflammation is closely related to the risk of atherosclerotic cardiovascular disease, with the neutrophil to lymphocyte ratio (NLR) being a potential indicator. However, the study found that NLR was positively associated with cross-sectional measures of carotid intima-media thickness but not with its progression, and no significant association was found between NLR and incident vascular events.

BIOFACTORS (2022)

Article Medicine, Research & Experimental

Beneficial effects of PCSK9 inhibition with alirocumab in familial hypercholesterolemia involve modulation of new immune players

Patrice Marques et al.

Summary: Inhibiting PCSK9 function can impact systemic inflammation and endothelial dysfunction by constraining leukocyte-endothelium interactions, enhancing T-regulatory cell activation, and reducing inflammatory response.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Pharmacology & Pharmacy

Dapagliflozin exerts anti-inflammatory effects via inhibition of LPS-induced TLR-4 overexpression and NF-κB activation in human endothelial cells and differentiated macrophages

Elaheh Abdollahi et al.

Summary: Evidence suggests that the new class of anti-diabetic drugs, SGLT2 inhibitors, can have beneficial effects on atherosclerotic complications of diabetes. This study aimed to evaluate the direct anti-inflammatory effects of the SGLT2 inhibitor dapagliflozin (DAPA). The results showed that DAPA could attenuate inflammation by inhibiting the expression of TLR-4 and activation of NF-kappa B, as well as shifting macrophage polarization from an inflammatory state to an anti-inflammatory state.

EUROPEAN JOURNAL OF PHARMACOLOGY (2022)

Article Cardiac & Cardiovascular Systems

Inflammation biomarkers and incident coronary heart disease: the Reasons for Geographic And Racial Differences in Stroke Study

Oluwasegun P. Akinyelure et al.

Summary: This study found that the number of inflammation markers in abnormal levels is associated with an increased risk of incident coronary heart disease.

AMERICAN HEART JOURNAL (2022)

Review Biochemistry & Molecular Biology

Inflammation and atherosclerosis: signaling pathways and therapeutic intervention

Peng Kong et al.

Summary: Atherosclerosis is a chronic inflammatory vascular disease that can be promoted or inhibited by innate and adaptive immune responses. Several signaling pathways associated with the inflammatory response have been found to play important roles in the development and regression of atherosclerosis. Targeting inflammatory pathways may represent a new approach for the treatment of atherosclerotic diseases.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Immunology

How the immune system shapes atherosclerosis: roles of innate and adaptive immunity

Payel Roy et al.

Summary: Atherosclerosis involves an inappropriate inflammatory response, with crucial roles played by immune cells. Understanding the regulatory mechanisms of immune cells in atherosclerosis is crucial for developing therapeutic interventions.

NATURE REVIEWS IMMUNOLOGY (2022)

Article Biochemistry & Molecular Biology

MiR-140-5p inhibits oxidized low-density lipoprotein-induced oxidative stress and cell apoptosis via targeting toll-like receptor 4

Huifang Liu et al.

Summary: The study demonstrates that miR-140-5p can participate in inhibiting oxidative stress and cell apoptosis in atherosclerosis by targeting TLR4.

GENE THERAPY (2021)

Article Cardiac & Cardiovascular Systems

PCSK9Qβ-003 Vaccine Attenuates Atherosclerosis in Apolipoprotein E-Deficient Mice

Danyu Wu et al.

Summary: The PCSK9Q beta-003 vaccine demonstrated its effectiveness in lowering LDL cholesterol, reducing plaque area, promoting plaque stability, regulating cholesterol transport, inhibiting inflammation infiltration, and reducing apoptosis in atherosclerosis, providing a potential novel therapeutic approach for the disease.

CARDIOVASCULAR DRUGS AND THERAPY (2021)

Article Cardiac & Cardiovascular Systems

PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Enhances Platelet Activation, Thrombosis, and Myocardial Infarct Expansion by Binding to Platelet CD36

Zhiyong Qi et al.

Summary: PCSK9 in plasma directly enhances platelet activation and in vivo thrombosis by binding to platelet CD36 and activating downstream signaling pathways. PCSK9 inhibitors or aspirin can abolish the enhancing effects of PCSK9.

CIRCULATION (2021)

Article Cell Biology

LncRNA OIP5-AS1 facilitates ox-LDL-induced endothelial cell injury through the miR-98-5p/HMGB1 axis

Zhanqiang Zheng et al.

Summary: Our study demonstrated that lncRNA OIP5-AS1 accelerates ox-LDL-induced endothelial cell injury by regulating HMGB1 via the miR-98-5p-mediated TLR4/NF-kappa B signaling pathway.

MOLECULAR AND CELLULAR BIOCHEMISTRY (2021)

Editorial Material Cardiac & Cardiovascular Systems

PCSK9 (Proprotein Convertase Subtilisin/Kexin 9) Goes DAMP

Roy L. Silverstein

CIRCULATION (2021)

Review Pharmacology & Pharmacy

The State of the Problem of Achieving Extremely Low LDL Levels

Victoria Korneva et al.

Summary: Clinical trials have shown that patients with very low LDL-C levels have the lowest cardiovascular risk, but the minimum permissible target values of lipids remain controversial. Some studies indicate potential unfavorable consequences of low LDL-C levels.

CURRENT PHARMACEUTICAL DESIGN (2021)

Review Medicine, General & Internal

PCSK9 and atherosclerosis: Looking beyond LDL regulation

Rosetta Ragusa et al.

Summary: PCSK9 is involved in regulating cholesterol homeostasis and may also be associated with vascular inflammation in atherogenesis. It is expressed by various cell types and detected inside atherosclerotic plaques, potentially playing a role in the molecular processes of atherosclerosis.

EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2021)

Review Cardiac & Cardiovascular Systems

Critical Role of LOX-1-PCSK9 Axis in the Pathogenesis of Atheroma Formation and Its Instability

Jonathan Tam et al.

Summary: The reciprocal relationship between PCSK9 and LOX-1 amplifies pro-inflammatory activity and gene expression, contributing to the pathogenesis of atherosclerosis. Further understanding of the LOX-1-PCSK9 axis has tremendous translational potential for designing novel management approaches for atherosclerosis.

HEART LUNG AND CIRCULATION (2021)

Review Plant Sciences

Regulation of pri-MIRNA processing: mechanistic insights into the miRNA homeostasis in plant

Jayanti Jodder

Summary: miRNAs in plants play a crucial role in controlling growth, development, and stress tolerance by modulating the expression of target genes. Modulating the expression of specific stress/development-related genes can be achieved by targeting the corresponding miRNAs. Understanding the molecular mechanism of miRNA biogenesis, particularly the processing of pri-MIRNAs, is essential for effectively modulating miRNA expression levels and ultimately improving plant yield and stress tolerance.

PLANT CELL REPORTS (2021)

Editorial Material Cardiac & Cardiovascular Systems

PCSK9-targeted therapies: present and future approaches

Mahmoud Al Rifai et al.

Summary: Human genetic studies combined with biotechnological advances have accelerated the development of PCSK9-targeting therapies. The focus is on reducing LDL cholesterol levels and preventing atherosclerotic cardiovascular disease.

NATURE REVIEWS CARDIOLOGY (2021)

Article Multidisciplinary Sciences

Myricetin ameliorates ox-LDL-induced HUVECs apoptosis and inflammation via lncRNA GAS5 upregulating the expression of miR-29a-3p

Yunpeng Bai et al.

Summary: The study demonstrated that Myricetin (Myr) preconditioning can prevent ox-LDL-induced injury in HUVECs by regulating GAS5 and miR-29a-3p, showcasing its anti-oxidant and anti-EndMT properties. Myr may have a therapeutic potential for atherosclerosis through inactivating the TLR4/NF-kappa B signaling pathway in ox-LDL-treated HUVECs.

SCIENTIFIC REPORTS (2021)

Review Pathology

Proprotein Convertase Subtilisin/Kexin Type 9 A View beyond the Canonical Cholesterol-Lowering Impact

Chiara Macchi et al.

Summary: PCSK9, mainly synthesized and released by the liver, is a key regulator of low-density lipoprotein cholesterol, with potential non-cholesterol-related effects in inflammatory burden, triglyceride-rich lipoprotein metabolism, platelet activation, and possibly in diseases such as diabetes, obesity, and cancer. Further research is needed to understand the diverse roles of PCSK9 in various physiological and pathological processes.

AMERICAN JOURNAL OF PATHOLOGY (2021)

Article Medicine, Research & Experimental

Ubiquitinated ligation protein NEDD4L participates in MiR-30a-5p attenuated atherosclerosis by regulating macrophage polarization and lipid metabolism

Fei Song et al.

Summary: MiR-30a-5p plays a significant role in reducing atherosclerotic lesions, levels of lipoproteins and pro-inflammatory cytokines, and increasing anti-inflammatory cytokines in Apo E-/- mice. It also regulates the M1/M2 macrophage ratio through Smad-1/2 phosphorylation and reduces lipid uptake in macrophages by modulating the expression of certain proteins. Ubiquitinated ligase NEDD4L is identified as a target of miR-30a-5p, which further influences the M1/M2 ratio and lipid uptake in macrophages.

MOLECULAR THERAPY-NUCLEIC ACIDS (2021)

Article Pharmacology & Pharmacy

A phase I study assessing the safety, tolerability, immunogenicity, and low-density lipoprotein cholesterol-lowering activity of immunotherapeutics targeting PCSK9

Markus Zeitlinger et al.

Summary: The study aimed to investigate the safety, tolerability, antibody development, and reduction of LDLc following four subcutaneous immunizations. Results showed that while both vaccine candidates were safe and immunogenic, only AT04A demonstrated significant LDLc-lowering activity.

EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2021)

Article Medicine, Research & Experimental

Astragaloside regulates lncRNA LOC100912373 and the miR-17-5p/PDK1 axis to inhibit the proliferation of fibroblast-like synoviocytes in rats with rheumatoid arthritis

Hui Jiang et al.

Summary: The study demonstrates that astragaloside inhibits fibroblast-like synoviocytes proliferation by regulating the expression of lncRNA LOC100912373 and the miR-17-5p/PDK1 axis.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2021)

Article Medicine, General & Internal

IL-6 inhibition with ziltivekimab in patients at high atherosclerotic risk (RESCUE): a double-blind, randomised, placebo-controlled, phase 2 trial

Paul M. Ridker et al.

Summary: This study investigated the safety and efficacy of IL-6 inhibition treatment in high cardiovascular risk individuals. Results showed that ziltivekimab effectively reduced biomarkers of inflammation and thrombosis, with promising effects observed in patients with chronic kidney disease.

LANCET (2021)

Review Endocrinology & Metabolism

Emerging role of non-coding RNA in health and disease

Gurjit Kaur Bhatti et al.

Summary: This article comprehensively discusses various strategies, techniques, and mechanisms of genetic disorders across different disease types including cardiovascular diseases, neurodegenerative diseases, cancers, and infectious diseases. It also explores the discovery, biogenesis, classification, and evolutionary prospects of non-coding RNAs, and their integrated networks with processes like chromatin remodeling, dosage compensation, and genome imprinting.

METABOLIC BRAIN DISEASE (2021)

Review Biotechnology & Applied Microbiology

Targeting inflammation in atherosclerosis - from experimental insights to the clinic

Oliver Soehnlein et al.

Summary: Inflammation plays a substantial role in atherosclerosis and targeting inflammatory pathways could provide a promising new avenue to prevent and treat the disease. Clinical studies have shown that modulation of inflammation can help prevent the clinical complications of atherosclerosis. Refining strategies for combatting inflammation in the disease is crucial for further progress in managing atherosclerotic risk.

NATURE REVIEWS DRUG DISCOVERY (2021)

Review Cardiac & Cardiovascular Systems

PCSK9 Functions in Atherosclerosis Are Not Limited to Plasmatic LDL-Cholesterol Regulation

Aureli Luquero et al.

Summary: The role of PCSK9 in atherosclerosis progression involves mechanisms such as lipid-lowering effects, regulation of key receptors in macrophages, and modulation of vascular inflammation. Inhibition of PCSK9 activity has been shown to reduce the progression of atherosclerotic disease.

FRONTIERS IN CARDIOVASCULAR MEDICINE (2021)

Article Biochemistry & Molecular Biology

miR-141-5p suppresses vascular smooth muscle cell inflammation, proliferation, and migration via inhibiting the HMGB1/NF-κB pathway

Yadong Li et al.

Summary: The study identified that miR-141-5p is downregulated in the plasma and VSMCs of AS patients and animal models. It functions as a protective factor during the development of AS by targeting the HMGB1/NF-kappa B pathway to inhibit VSMCs dysfunction.

JOURNAL OF BIOCHEMICAL AND MOLECULAR TOXICOLOGY (2021)

Article Cardiac & Cardiovascular Systems

Long Noncoding RNA MALAT1 Regulates the Progression of Atherosclerosis by miR-330-5p/NF-κB Signal Pathway

Zhifeng Shi et al.

Summary: The study found that in atherosclerosis, MALAT1 promotes inflammation by regulating miR-330-5p and the NF-κB signal pathway, driving the progression of the disease, and providing a new biomarker for its diagnosis.

JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2021)

Article Cell Biology

LincRNA-p21 alleviates atherosclerosis progression through regulating the miR-221/SIRT1/Pcsk9 axis

Haojie Wang et al.

Summary: The study showed that LincRNA-p21 acted as a molecular sponge for miR-221 to promote deacetylation of the promoter region of Pcsk9 by SIRT1, thereby preventing the development of AS.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2021)

Article Medicine, General & Internal

Knockdown of circ_0003204 alleviates oxidative low-density lipoprotein-induced human umbilical vein endothelial cells injury: Circulating RNAs could explain atherosclerosis disease progression

Qiuxia Su et al.

Summary: The study revealed that circ_0003204 is highly expressed in ox-LDL-induced HUVECs and its silencing can suppress ox-LDL-induced cell injury. miR-330-5p can be sponged by circ_0003204, and overexpression of TLR4 can reverse the inhibitory effect of miR-330-5p on ox-LDL-induced cell injury. The NF-kappa B signaling pathway is regulated by the circ_0003204/miR-330-5p/TLR4 axis, indicating circ_0003204 as a potential novel target for AS treatment.

OPEN MEDICINE (2021)

Review Cardiac & Cardiovascular Systems

PCSK9 and inflammation: role of shear stress, pro-inflammatory cytokines, and LOX-1

Zufeng Ding et al.

CARDIOVASCULAR RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Hsa-miR-140-5p down-regulates LDL receptor and attenuates LDL-C uptake in human hepatocytes

Yaqiong Xu et al.

ATHEROSCLEROSIS (2020)

Review Oncology

Long non-coding RNAs in development and disease: conservation to mechanisms

Ioannis Tsagakis et al.

JOURNAL OF PATHOLOGY (2020)

Review Pharmacology & Pharmacy

Mechanisms of Medicinal Plant Activity on Nitric Oxide (NO) Bioavailability as Prospective Treatments for Atherosclerosis

Khojasteh Malekmohammad et al.

CURRENT PHARMACEUTICAL DESIGN (2020)

Article Cell Biology

Modulation of circRNA Metabolism by m6A Modification

Gaia Di Timoteo et al.

CELL REPORTS (2020)

Review Cell Biology

The expanding regulatory mechanisms and cellular functions of circular RNAs

Ling-Ling Chen

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2020)

Article Medicine, General & Internal

Two Phase 3 Trials of Inclisiran in Patients with Elevated LDL Cholesterol

Kausik K. Ray et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Cardiac & Cardiovascular Systems

Meta-Analysis of Leukocyte Diversity in Atherosclerotic Mouse Aortas

Alma Zernecke et al.

CIRCULATION RESEARCH (2020)

Article Cardiac & Cardiovascular Systems

Microanatomy of the Human Atherosclerotic Plaque by Single-Cell Transcriptomics

Marie A. C. Depuydt et al.

CIRCULATION RESEARCH (2020)

Article Medicine, General & Internal

Colchicine in Patients with Chronic Coronary Disease

Stefan M. Nidorf et al.

NEW ENGLAND JOURNAL OF MEDICINE (2020)

Review Cell Biology

Cellular Mechanisms and Regulation of Quiescence

Oceane Marescal et al.

DEVELOPMENTAL CELL (2020)

Article Medicine, Research & Experimental

NLRP3 inflammasome via IL-1 13 regulates PCSK9 secretion

Zufeng Ding et al.

THERANOSTICS (2020)

Article Pharmacology & Pharmacy

LncRNAs in vascular biology and disease

Viorel Simion et al.

VASCULAR PHARMACOLOGY (2019)

Article Pharmacology & Pharmacy

Non-coding RNA regulation of endothelial and macrophage functions during atherosclerosis

Binod Aryal et al.

VASCULAR PHARMACOLOGY (2019)

Review Cell Biology

PCSK9: A novel inflammation modulator in atherosclerosis?

Zhi-Han Tang et al.

JOURNAL OF CELLULAR PHYSIOLOGY (2019)

Article Multidisciplinary Sciences

Sleep modulates haematopoiesis and protects against atherosclerosis

Cameron S. McAlpine et al.

NATURE (2019)

Review Biochemistry & Molecular Biology

An update on lipid oxidation and inflammation in cardiovascular diseases

Shanshan Zhong et al.

FREE RADICAL BIOLOGY AND MEDICINE (2019)

Review Pharmacology & Pharmacy

Emerging role of proprotein convertase subtilisin/kexin type-9 (PCSK-9) in inflammation and diseases

Madalyn Brown et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)

Article Biochemistry & Molecular Biology

Long Non-coding RNA BACE1-AS May Serve as an Alzheimer's Disease Blood-Based Biomarker

Seyedeh Nahid Fotuhi et al.

JOURNAL OF MOLECULAR NEUROSCIENCE (2019)

Review Medicine, General & Internal

Inflammation as a Therapeutic Target in Atherosclerosis

Mau T. Nguyen et al.

JOURNAL OF CLINICAL MEDICINE (2019)

Review Cardiac & Cardiovascular Systems

PCSK9 and inflammation: a review of experimental and clinical evidence

Amir Abbas Momtazi-Borojeni et al.

EUROPEAN HEART JOURNAL-CARDIOVASCULAR PHARMACOTHERAPY (2019)

Review Biochemistry & Molecular Biology

The role of long noncoding RNA in major human disease

Xiaoli Zhang et al.

BIOORGANIC CHEMISTRY (2019)

Article Medicine, General & Internal

Efficacy and Safety of Low-Dose Colchicine after Myocardial Infarction

Jean-Claude Tardif et al.

NEW ENGLAND JOURNAL OF MEDICINE (2019)

Article Hematology

CD36 Enhances Vascular Smooth Muscle Cell Proliferation and Development of Neointimal Hyperplasia

Hong Yue et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Review Pharmacology & Pharmacy

THE ATHEROSCLEROSIS-INFLAMMATION RELATIONSHIP - A PATHOPHYSIOLOGICAL APPROACH

Denisa-Madalina Zalar et al.

FARMACIA (2019)

Article Biochemistry & Molecular Biology

Deletion of the Mir-106b∼ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice

Jonathan Semo et al.

LIPIDS IN HEALTH AND DISEASE (2019)

Article Cardiac & Cardiovascular Systems

Long-term exposure to air pollution raises circulating levels of proprotein convertase subtilisin/kexin type 9 in obese individuals

Chiara Macchi et al.

EUROPEAN JOURNAL OF PREVENTIVE CARDIOLOGY (2019)

Article Medicine, General & Internal

MiR-590 Inhibits Endothelial Cell Apoptosis by Inactivating the TLR4/NF-κB Pathway in Atherosclerosis

Lei Yang et al.

YONSEI MEDICAL JOURNAL (2019)

Review Biochemistry & Molecular Biology

Understanding Long Noncoding RNA and Chromatin Interactions: What We Know So Far

Kankadeb Mishra et al.

NON-CODING RNA (2019)

Review Cardiac & Cardiovascular Systems

Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives

Wolfgang Poller et al.

EUROPEAN HEART JOURNAL (2018)

Article Medicine, Research & Experimental

Microrna-145 accelerates the inflammatory reaction through activation of NF-κB signaling in atherosclerosis cells and mice

Li Sheng et al.

BIOMEDICINE & PHARMACOTHERAPY (2018)

Article Cardiac & Cardiovascular Systems

PCSK9 regulates expression of scavenger receptors and ox-LDL uptake in macrophages

Zufeng Ding et al.

CARDIOVASCULAR RESEARCH (2018)

Article Cell Biology

Expression profiles of microRNAs in oxidized low-density lipoprotein-stimulated RAW 264.7 cells

Xiaokai Li et al.

IN VITRO CELLULAR & DEVELOPMENTAL BIOLOGY-ANIMAL (2018)

Article Biochemistry & Molecular Biology

MiR-135a represses oxidative stress and vascular inflammatory events via targeting toll-like receptor 4 in atherogenesis

Xian-Jin Du et al.

JOURNAL OF CELLULAR BIOCHEMISTRY (2018)

Letter Cardiac & Cardiovascular Systems

PCSK9 as a Positive Modulator of Platelet Activation

Marina Camera et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)

Article Multidisciplinary Sciences

PCSK9 induces a pro-inflammatory response in macrophages

Chiara Ricci et al.

SCIENTIFIC REPORTS (2018)

Article Biochemistry & Molecular Biology

MicroRNA-98 regulates foam cell formation and lipid accumulation through repression of LOX-1

Yao Dai et al.

REDOX BIOLOGY (2018)

Review Cardiac & Cardiovascular Systems

Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions

Paolo Raggi et al.

ATHEROSCLEROSIS (2018)

Article Medicine, Research & Experimental

Endothelial cell CD36 optimizes tissue fatty acid uptake

Ni-Huiping Son et al.

JOURNAL OF CLINICAL INVESTIGATION (2018)

Review Cardiac & Cardiovascular Systems

Novel Insights in the Metabolic Syndrome-induced Oxidative Stress and Inflammation-mediated Atherosclerosis

Johnna F. Varghese et al.

CURRENT CARDIOLOGY REVIEWS (2018)

Article Cardiac & Cardiovascular Systems

Association of PCSK9 with platelet reactivity in patients with acute coronary syndrome treated with prasugrel or ticagrelor: The PCSK9-REACT study

Eliano P. Nayarese et al.

INTERNATIONAL JOURNAL OF CARDIOLOGY (2017)

Article Medicine, Research & Experimental

MicroRNA let-7g alleviates atherosclerosis via the targeting of LOX-1 in vitro and in vivo

Mingxin Liu et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2017)

Article Cardiac & Cardiovascular Systems

Relationship of PCSK9 and Urinary Thromboxane Excretion to Cardiovascular Events in Patients With Atrial Fibrillation

Daniele Pastori et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)

Article Medicine, General & Internal

Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease

P. M. Ridker et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Biochemistry & Molecular Biology

LncRNA-mediated regulation of cell signaling in cancer

W-X Peng et al.

ONCOGENE (2017)

Article Medicine, Research & Experimental

MicroRNA-98 rescues proliferation and alleviates ox-LDL-induced apoptosis in HUVECs by targeting LOX-1

Zhibo Chen et al.

EXPERIMENTAL AND THERAPEUTIC MEDICINE (2017)

Review Biotechnology & Applied Microbiology

Circular RNAs in Cardiovascular Disease: An Overview

Ximin Fan et al.

BIOMED RESEARCH INTERNATIONAL (2017)

Review Pharmacology & Pharmacy

Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis

Bin Li et al.

CURRENT PHARMACEUTICAL DESIGN (2017)

Review Cell Biology

Cis- and trans-acting lncRNAs in pluripotency and reprogramming

Pixi Yan et al.

CURRENT OPINION IN GENETICS & DEVELOPMENT (2017)

Review Cardiac & Cardiovascular Systems

The sirtuin family members SIRT1, SIRT3 and SIRT6: Their role in vascular biology and atherogenesis

Bozena Sosnowska et al.

ATHEROSCLEROSIS (2017)

Article Biochemistry & Molecular Biology

Structural basis for ligand capture and release by the endocytic receptor ApoER2

Hidenori Hirai et al.

EMBO REPORTS (2017)

Review Biochemistry & Molecular Biology

CircRNAs: a regulator of cellular stress

Joseph W. Fischer et al.

CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)

Article Biochemistry & Molecular Biology

Suppressor of Cytokine Signaling-3 (SOCS-3) Induces Proprotein Convertase Subtilisin Kexin Type 9 (PCSK9) Expression in Hepatic HepG2 Cell Line

Massimiliano Ruscica et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2016)

Article Cell Biology

The human rs1050286 polymorphism alters LOX-1 expression through modifying miR-24 binding

Elena Morini et al.

JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)

Review Oncology

From junk to master regulators of invasion: lncRNA functions in migration, EMT and metastasis

Sonam Dhamija et al.

INTERNATIONAL JOURNAL OF CANCER (2016)

Article Medicine, Research & Experimental

MicroRNA-16 suppresses the activation of inflammatory macrophages in atherosclerosis by targeting PDCD4

Xue Liang et al.

INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE (2016)

Article Cell Biology

NF-κB-Regulated miR-99a Modulates Endothelial Cell Inflammation

Mei-hua Bao et al.

MEDIATORS OF INFLAMMATION (2016)

Review Biochemistry & Molecular Biology

The roles of non-coding RNAs in Parkinson's disease

Maryam Majidinia et al.

MOLECULAR BIOLOGY REPORTS (2016)

Review Immunology

Innate sensing of oxidation-specific epitopes in health and disease

Christoph J. Binder et al.

NATURE REVIEWS IMMUNOLOGY (2016)

Article Cardiac & Cardiovascular Systems

microRNA-185 modulates low density lipoprotein receptor expression as a key posttranscriptional regulator

Huajun Jiang et al.

ATHEROSCLEROSIS (2015)

Review Cardiac & Cardiovascular Systems

Molecular and cellular function of the proprotein convertase subtilisin/kexin type 9 (PCSK9)

Rainer Schulz et al.

BASIC RESEARCH IN CARDIOLOGY (2015)

Review Biochemistry & Molecular Biology

The influence of dysfunctional signaling and lipid homeostasis in mediating the inflammatory responses during atherosclerosis

Melanie L. Buckley et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2015)

Review Cardiac & Cardiovascular Systems

Protective effects of sirtuins in cardiovascular diseases: from bench to bedside

Stephan Winnik et al.

EUROPEAN HEART JOURNAL (2015)

Article Biochemistry & Molecular Biology

miR-223 Inhibits Lipid Deposition and Inflammation by Suppressing Toll-Like Receptor 4 Signaling in Macrophages

Jun Wang et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)

Review Surgery

Role of high shear rate in thrombosis

Lauren D. C. Casa et al.

JOURNAL OF VASCULAR SURGERY (2015)

Article Respiratory System

Non-coding RNAs and respiratory disease

Pieter Mestdagh et al.

THORAX (2015)

Review Cardiac & Cardiovascular Systems

PCSK9: From discovery to therapeutic applications

Michel Farnier

ARCHIVES OF CARDIOVASCULAR DISEASES (2014)

Article Peripheral Vascular Disease

Noncoding RNAs and Atherosclerosis

Binod Aryal et al.

CURRENT ATHEROSCLEROSIS REPORTS (2014)

Review Biochemistry & Molecular Biology

PCSK9 and LDLR degradation: regulatory mechanisms in circulation and in cells

Thomas A. Lagace

CURRENT OPINION IN LIPIDOLOGY (2014)

Article Obstetrics & Gynecology

MicroRNA: key gene expression regulators

Juan Manuel Moreno-Moya et al.

FERTILITY AND STERILITY (2014)

Article Pharmacology & Pharmacy

Relation of circulating PCSK9 concentration to fibrinogen in patients with stable coronary artery disease

Yan Zhang et al.

JOURNAL OF CLINICAL LIPIDOLOGY (2014)

Article Immunology

Standardizing Scavenger Receptor Nomenclature

Mercy PrabhuDas et al.

JOURNAL OF IMMUNOLOGY (2014)

Article Biochemistry & Molecular Biology

Alirocumab inhibits atherosclerosis, improves the plaque morphology, and enhances the effects of a statin

Susan Kuhnast et al.

JOURNAL OF LIPID RESEARCH (2014)

Review Geriatrics & Gerontology

Mineralization of the Connective Tissue: A Complex Molecular Process Leading to Age-Related Loss of Function

Anastasia V. Shindyapina et al.

REJUVENATION RESEARCH (2014)

Article Biochemistry & Molecular Biology

In-Silico Algorithms for the Screening of Possible microRNA Binding Sites and Their Interactions

Harsh Dweep et al.

CURRENT GENOMICS (2013)

Article Cardiac & Cardiovascular Systems

Extramedullary Hematopoiesis Generates Ly-6Chigh Monocytes That Infiltrate Atherosclerotic Lesions

Clinton S. Robbins et al.

CIRCULATION (2012)

Review Medical Laboratory Technology

Molecular pathology of familial hypercholesterolemia, related dyslipidemias and therapies beyond the statins

Fathimath Faiz et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2012)

Editorial Material Medicine, Research & Experimental

Taming endothelial activation with a microRNA

Jason E. Fish et al.

JOURNAL OF CLINICAL INVESTIGATION (2012)

Review Biotechnology & Applied Microbiology

The biology and therapeutic targeting of the proprotein convertases

Nabil G. Seidah et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Peripheral Vascular Disease

Atherosclerosis: An Epigenetic Balancing Act that Goes Wrong

Gertrud Lund et al.

CURRENT ATHEROSCLEROSIS REPORTS (2011)